Table 1.
Clinical characteristics.
| NGT | All T2D | T2D HbA1c <7.0% |
T2D HbA1c >7.0% |
|
|---|---|---|---|---|
| N (F/M) | 12 (12/0) | 28 (7/21) | 7 (3/4) | 17 (3/14) |
| Age (years) | 39.5 ± 2.5 | 51.2 ± 1.3*** | 48.4 ± 1.9** | 50.9 ± 1.9** |
| BMI (kg/m2) | 50.4 ± 2.1 | 37.9 ± 1.6*** | 45.8 ± 1.4 | 36.9 ± 2.0***,§ |
| FPG (mmol/L) | 5.24 ± 0.21 | 10.46 ± 0.74*** | 6.5 ± 0.5* | 11.9 ± 0.95***,§§ |
| FPI (pmol/L) | 129.9 [45.5] | 119.1 [95.6] | 168.6 [89.3] | 111.6 [108.6] |
| HbA1C (%)a | 5.8 ± 0.2 | 8.4 ± 0.37** | 6.3 ± 0.2* | 9.3 ± 0.3**,§§§ |
*P < 0.05, **P < 0.01, ***P < 0.001 versus NGT and §P < 0.05, §§P < 0.01, §§§P < 0.001 vs T2D HbA1c<7.0%, by Mann–Whitney test.
a
Available for 5 out of 12 NGT subjects and 24 out of 28 T2D patients.